Type 2 Diabetes Epidemic in India Combated with use of Blockchain

A pioneering diabetes pilot to collect, sequence and analyze DNA in India, may help explain why the country has one of the highest rising prevalence of the type 2 diabetes in the world. The aim is to use the data for improved diagnosis and treatment of this disease that is devastating the country.

Genomics and precision medicine startup Shivom is working with diagnostic partner Genetic Technologies Limited (GTG; ASX:GTG; NASDAQ:GENE) with the goal of finding unique genetic markers specific to Indian sub-populations.  Diabetes is a disease characterized by high levels of blood glucose. Over longer periods of time it leads to serious damage to the heart, blood vessels, eyes, kidneys and nerve system.

Incidences of type 2 diabetes in India have more than quadrupled in the last 35 years, with communities developing the disease at younger ages and at lower body weights than other populations. According to the World health Organization, around 72 million Indians have the disease.

The ground-breaking pilot involves thousands of patients and will start in the south-eastern state of Andhra Pradesh – some of whom have already been diagnosed with type 2 diabetes, and control participants who don’t have the disease.

Leave a Reply

Your email address will not be published. Required fields are marked *